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Zinc-finger nucleases and transcription activator-like effector nucleases are novel gene-editing platforms
contributing to redefine the boundaries of modern biological research. They are composed of a non-specific
cleavage domain and a tailor made DNA-binding module, which enables a broad range of genetic modifications by
inducing efficient DNA double-strand breaks at desired loci. Among other remarkable uses, these nucleases have
been employed to produce gene knockouts in mid-size and large animals, such as rabbits and pigs, respectively.
This approach is cost effective, relatively quick, and can produce invaluable models for human disease studies,
biotechnology or agricultural purposes. Here we describe a protocol for the efficient generation of knockout rabbits
using transcription activator-like effector nucleases, and a perspective of the field.
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Background
Biomedical research is under growing pressure to ap-
proach translation to clinical practice. Before this happens,
there are safety concerns that cannot always be addressed
by traditional procedures and require the development
of suitable animal models. This is particularly obvious
in the field of regenerative medicine, where it is expected
that yet poorly understood stem cells or their derivatives
will be transplanted -sometimes in large numbers- into
patients [1]. Unquestionably, rodents (mostly mice) and
other small organisms have been instrumental for clarify-
ing the molecular pathways involved in human physiology
and disease. Mice are easily handled, relatively inexpen-
sive, and can be used in substantial numbers for providing
rigorous statistical analysis. However, their physiology is in
general rather different from humans, and their short life
span prevents longitudinal studies of safety and efficacy.* Correspondence: esteban@gibh.org; lai_liangxue@gibh.ac.cn
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unless otherwise stated.Accordingly, they frequently fall short of utility for transla-
tional research [1]. For example, mouse metabolic and
inflammatory responses have poor correlation with the
human conditions [2], the mouse and human retina are
anatomically and histologically different [1], and knocking
out the gene responsible for cystic fibrosis in humans
(CFTR) reproduces the disease in pigs but not in mice [3].
Thus, there is an urgent need to develop larger and more
complex animal models that can bypass these limitations.Rabbits in biomedical research
The choice of mid-size/large animal model (e.g., rabbits,
cats, dogs, cattle, horses, goats, pigs, or nonhuman pri-
mates) for scientific research depends on the disease/
condition to be studied, but is also influenced by other
considerations including the more or less privileged
position in the human community. Rabbits are small
herbivore mammals belonging to the order Lagomorpha
that are found ubiquitously. They are closer phylogenetic-
ally to humans than rodents, measure up to 50 cm in
length, and weight 2–5 kg, which makes them big enough
for certain procedures but relatively easy to handle. They
have as well a long life span (9–12 years), require low cost
maintenance, and have short pregnancy period with large
offspring. Nowadays, rabbits are extensively used as livetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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enriched in human proteins) [4], for orthopedic [5] and
ophthalmic (due to their large eyes with retina compos-
ition similar to humans) research [6], and also cardio-
vascular/metabolic disease studies [7]. The latter is of
relevance because cardiovascular and metabolic diseases
consume a huge part of the national health cost in any
country. In this regard, there are big differences in lipid
metabolism between humans and mice, while rabbits
are similar to humans in many aspects. For instance,
as opposed to humans, mice are highly resistant to
diet-induced atherosclerosis due to high levels of high-
density lipoproteins (HDL) in plasma, but rabbits are not
[7]. Nevertheless, in spite of these and other advantages
over other animals, rabbit experimentation beyond the
mentioned topics has been limited by the lack of compre-
hensive tools for genetic engineering. Transgenic rabbits
can be generated by microinjection of the desired DNA
construct (normally a lentivirus or bacterial artificial
chromosome) into a fertilized egg. This has allowed the
production of exceptional models such as the mutant
rhodopsin and mutant KCNQ1/KCNH2 rabbits, which
are employed to study retinitis pigmentosa [6] and long
QT syndrome [8], respectively. However, transgene over-
expression cannot reproduce many human diseases, and
the generation of gene substitutions/knockouts with
bacterial artificial chromosomes is rather inefficient.
Traditional genetic engineering of animals
In the past, the remarkable success of genetic engineer-
ing in mice has mostly depended on the isolation and
manipulation of embryonic stem cell lines (ESCs) using
standard homologous recombination techniques. ESCs
can be cultured for prolonged periods of time (thus
allowing lengthy handling) in an undifferentiated state,
and later on be employed for generating chimeric mice
with germline transmission by injection into heterologous
blastocysts. Since the isolation of the first mouse ESC line
in 1981 [9], there have been many attempts to generate
pluripotent stem cell lines from other species. Interest-
ingly, several groups have reported the isolation of rabbit
ESC-like cells [10]. These cell lines expressed stem cell-
associated markers and maintained apparent pluripotency
during multiple passages in vitro, but none of them have
been convincingly proven to produce chimera. Among the
few reported cases, Schoonjans et al. described low rate of
chimerism (5%) with high contribution based on the coat
color [11], and Zakhartchenko et al. a single live-born
chimera (with low level of mixed coat color) that died
shortly [12]. Other groups have produced rabbit induced
pluripotent stem cells [13,14] by reprogramming somatic
cells with a cocktail of exogenous transcription factors
[15], but these ESC-like cells failed as well to contribute to
chimeras or the procedure was not tested. The low rate ofchimera formation may be caused by a problem of the
ESCs to integrate into the inner cell mass, and/or from
failure of the incorporated ESCs to truly participate in em-
bryo development. This deficiency is not a technical issue
(e.g., because of the injection procedure or similar), as in
fact Gardner and Munro reported the generation of
chimeric rabbits by blastocyst injection of heterologous
inner cell mass cells as early as in 1974 [16]. Notably, a
valuable alternative for genetic modification that is fre-
quently employed in those species for which bona fide
ESCs have not been established (e.g. pigs and cattle) is the
generation of modified animals by nuclear transfer [17].
This method allows the genetic manipulation of the donor
somatic cells prior to transfer into an enucleated oocyte.
Yet, it has high frequency of developmental abnormalities
and also the caveat that somatic cells have limited lifespan,
thus permitting only simple substitutions (e.g., hetero-
zygous knockouts) by means of standard homologous
recombination techniques. Moreover, although rabbit
nuclear transfer pioneered the field, it is more challen-
ging than for other species and few successful cases
have been reported [10].
Genetic engineering with designer nucleases
To overcome the above-mentioned issues, a new tech-
nology termed “genome editing” has emerged that allows
investigators to modify virtually any gene in a variety of
organisms and cell types [18]. Two remarkable examples
of this novel approach are zinc-finger nucleases (ZFNs)
and transcription activator-like effector (TALE) nucleases
(TALENs). These 2 types of designer nucleases are com-
posed of a programmable module that can be adapted to
recognize specific genomic sequences, and a non-specific
DNA cleavage domain (Figure 1). This combination can
produce DNA double-strand breaks (DSBs) at specific
loci, which by means of error-prone nonhomologous end
joining or homology-directed repair can result in knock-
outs, nucleotide substitutions, knock-ins, and even larger
chromosomal rearrangements [18]. The zinc-finger do-
main is one of the most frequent motifs in mammalian
DNA-binding proteins. Its modular (ββα) structure ex-
poses several amino acids that recognize 3 base pairs in
the major groove of DNA [19]. Such unique mode of
action made attractive the design of multimodular
custom-made DNA-binding proteins with site-specific
affinities, which were then fused to the restriction endo-
nuclease FokI [19] and pioneered the field. On the other
hand, TALE proteins are naturally occurring proteins
from the plant pathogen Xanthomonas (a type of proteo-
bacteria) that contain individual repeats (each typically
consisting of 34 amino acids) targeting each a single
DNA base pair [20]. Like with ZFNs, TALE repeats can
be assembled into a multimodular protein that recog-
nizes contiguous DNA sequences (Figure 1). Yet, the
Figure 1 Schematic depiction of how ZFNs and TALENs recognize target DNA and induce genome editing. ZFP stands for zinc-finger
protein, NLS for nuclear localization signal, N-terminal and C-terminal for amino- and carboxyl-terminal, respectively. DSBs induced by the designer
nucleases can be repaired by homology-directed repair or nonhomologous end joining, which can result in knock-ins or knockouts, respectively.
FOKI can be substituted by other restriction endonucleases [22].
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of TALENs more flexible than ZFNs. In fact, a series of
systematized strategies have been developed that enable
relatively quick and affordable design/assembly compared
to the more tedious and costly ZFNs [18].
To solve the restrictions surrounding traditional gen-
etic engineering of rabbits, we and others have injected
mRNA encoding designer nucleases into fertilized
rabbit oocytes [21,22]. Flisikowska et al. reported the
generation of knockout rabbits for the immunoglobu-
lin M locus using ZFNs [21], and Song et al. knockouts
for both Rag 1 and 2 using TALENs [22]. The former
model can be used for producing therapeutic human
polyclonal antibodies, and the latter for bone marrow
gene therapy or cell transplantation studies. Below we
describe a step-by-step protocol for producing knock-
out rabbits using TALENs.
Basic protocol
Essential reagents/materials, reagent setup and
equipment
Golden Gate TALEN and TAL Effector Kit 2.0 (Addgene,
cat. no. 1000000024)
mMESSAGE mMACHINE® T7 Kit (Ambion, cat. no.
AM1344)
RNeasy Mini Elute Cleanup Kit (QIAgen, cat. no.
74204)Tergitol® Type NP-40 (Sigma, cat. no. NP40)
10× Taq Buffer (Takara, cat. no. R001A)
Proteinase K (Sigma, cat. no. P2308)
T7 Endonuclease I (New England Biolabs, cat no.
M0302S)
Pregnant mare’s serum gonadotropin (Ningbo Renjian
Pharmaceutical Co., Ltd., cat. no. 110254564)
Human chorionic gonadotropin (hCG; Ningbo Renjian
Pharmaceutical Co., Ltd., cat. no. 110251282)
New Zealand white rabbits (Experimental Animal Center
of Southern Medical University, Guangzhou, China)
Medium 199, Hank’s (Gibco, cat. no. 12350)
Fetal bovine serum (Hyclone, cat. no. SH30070.03)
Mineral oil (for embryos) (Thermo Fisher, cat. no.
8042-47-5)
Earle’s balanced salt solution (EBSS; Hyclone, cat. no.
SH30029.09)
Essential amino acid solution (Sigma, cat. no. B6766)
Non-essential amino acid solution (Sigma, cat. no.
M7145)
L-glutamine (Sigma, cat. no. G8540)
Sodium pyruvate (Sigma, cat. no. P4562)
Embryo lysis buffer: mix 1% NP40 and 50 ng/μl pro-
teinase K in 1× Taq buffer.
100× L–glutamine stock solution: Dissolve 0.146 g of
L-glutamine in 10 ml of EBSS to make the stock solu-
tion. Filter-sterilize with a 0.22-μm syringe filter, then
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100× sodium pyruvate stock solution: Dissolve 0.044 g
of sodium pyruvate in 10 ml of EBSS to make the stock
solution. Filter-sterilize with a 0.22-μm syringe filter,
then make 200-μl aliquots and store at 4°C for up to 1
month.
Embryo culture medium: The basic medium contains
EBSS supplemented with 1% nonessential amino acids
and 2% essential amino acids. It should be stored at 4°C
and used for up to 3 weeks. 100 μl of the glutamine
stock, 100 μl of the sodium pyruvate stock and 1 ml of
fetal bovine serum should be added to 8.8 ml of basic
medium before use.
Embryo manipulation medium: Medium 199, Hank’s
supplemented with 10% fetal bovine serum. Store at 4°C
for up to 3 weeks.
Borosilicate glass capillaries (WPI, cat. no. TW100-4;
for preparing the holding pipette)
Borosilicate glasses with filament (Sutter, cat. no. BF100-
78-10; for preparing the injection pipette)
Micromanipulator set system (Narishige, cat. no. ON3/
MP3.3/IPE5.1)
Pipette puller (Sutter, cat. no. P-97)
Microforge (Narishige, cat. no. MF900)
Stereoscopic microscope (Nikon, cat. no. SM2645)
Inverted microscope (Olympus, cat. no. IX71)
Microloader (Eppendorf, cat. no. A246525)
Procedure
I. TALEN design and preparation. TIME: ~7 days.Fig
(in1) Choose the target gene and locate the genomic
DNA sequence using Ensembl (www.ensembl.org).
For a complete knockout, the target region
should normally be within the first few exons
(exons 1 or 2) of your gene of interest. The
possibility of an additional transcription
initiation site or an internal translation initiation
site should be considered. We also recommend
performing PCR amplification and sequencing of
the selected region, as this can prevent mistakes
due to incorrect annotation of the rabbit genomeure 2 A Pair of TALENs used for targeting the rabbit Rag 1 gene. Red
red). The spacer has a length of 16 base pairs. We used the FOKI variants Eor rabbit breed variations. Partial rabbit genome
sequences are also included in NCBI (www.ncbi.
nlm.nih.org). If the target gene were not included
in any of the databases then a different strategy
(likely involving cloning) will be necessary.
2) Design the TALEN effector binding elements
(EBEs) using standard principles applied in your
laboratory. We routinely design 2 pairs of EBEs
(15-17 base pairs each) for each target gene. We
use the web-based public program TAL Effector
Nucleotide Targeter 2.0 (https://tale-nt.cac.cornell.
edu) for designing the EBEs. After obtaining
candidates with this program, we adhere to 3
main principles derived from the reports by
Cermak et al. and Doyle et al. [20,23] (Figure 2).
First, the EBEs (on the sense and antisense
genomic DNA strand) should be preceded by a
5′-T. Second, the average G nucleotide
composition of the left EBE should be less than
25%, and the same applies to the average C
composition of the right EBE. Third, the
optimum spacer length between the 2 EBEs
should be 15-17 base pairs.
3) Assemble the TALENs using the Golden Gate
TALEN assembly kit [20,23]; the details of this
method won’t be discussed here. There are other
methods available for TALEN assembly including
PCR-based modular assembly [24], FLASH
assembly [25], as well as commercial approaches.
II. In vitro and in vivo testing of TALENs.
4) Single-strand annealing (SSA) detection. The SSA
pathway of homologous recombination repairs
DSBs between 2 repeated sequences and is used
to test TALEN cutting efficiency in vitro [26].
TIME: ~5-7 days (not including vector
preparation).circles
LD anda. Construct a “dead” reporter plasmid by
inserting the DNA sequence targeted by the
TALENs’ EBEs and the spacer sequence (~48
base pairs) into the GFP (green fluorescent
protein) coding sequence (Figure 3A). A
similar readout can be obtained by creating a
“dead” luciferase reporter plasmid [26].show a 5′-T preceding the TALEN EBE binding sequences
KKR [22].
Figure 3 In vitro and in vivo testing of TALENs. A. Schematic depiction of the SSA test as explained in step 4 of the procedure. B. Flow
cytometry analysis of HEK 293 T cells transfected with a GFP “dead” reporter shows increased GFP activity with co-transfection of a specific pair of
TALEN plasmids compared to the control. C. T7 endonuclease I test result. Lanes 1 and 2 are negative controls, 3 and 5 are samples A and B
before treatment, respectively, 4 and 6 are samples A and B after treatment, respectively. White arrows indicate the expected fragments after
cleavage by T7 endonuclease I; bp stands for base pairs.
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TALEN plasmids into HEK 293 T cells. If the
TALENs produce DSBs then the TALEN target
sequence would be removed away by the SSA.
This will cause that the cells express GFP,
which can be observed with a fluorescence
microscope and/or quantified by flow
cytometry. The latter can help discern which
TALENs display higher activity (Figure 3B).
Notably, the results from the GFP or luciferase
test don’t represent the real activity of
TALENs in living cells or embryos. In fact,
epigenetic modifications inducing a closed
chromatin conformation (e.g., DNA
methylation) are known to reduce TALEN
cutting efficiency [27].
5) T7 endonuclease I test. This enzyme recognizes
and cleaves non-perfectly matched DNA. It can
thus be employed to confirm the TALENs’ activity
in vivo because the DSBs produced by TALENs
will generate various kinds of indels in the DNA
of these embryos. The latter will result in
non-perfectly matched DNA heteroduplexes after
denaturing and reannealing the PCR products forthe region of interest in vitro. TIME: ~10-12 hours
(not including mRNA preparation and embryo
injection).
a. Prepare in vitro translated TALEN-coding
mRNAs (see step 6 below). Microinject the
mRNAs into rabbit embryos (see step 10
below) and harvest the embryos with embryo
lysis buffer 5 days later.
b. Use this lysate to amplify the DNA sequence
containing the TALEN target region by PCR.
c. Subject the PCR product to denaturation and
reannealing to obtain DNA heteroduplexes.
Incubate the product with T7 endonuclease I
at 37°C for 15 minutes, and stop the reaction
with 0.5 M EDTA. The mixture is then ready
for electrophoresis on a polyacrylamide gel. If
the TALENs are effective there should be at
least 3 bands (the original PCR product and 2
bands resulting from the T7 endonuclease I
cleavage), rather than just 1 (Figure 3C).
III. In vitro transcription of TALEN-coding mRNAs.
TIME: ~1 day.
6) Choose one pair of TALENs with high activity.
Linearize the corresponding plasmids with an
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into mRNA using the mMESSAGE mMACHINE®
T7 Kit from Ambion. Please note that the
backbone vector expressing the TALENs should
contain the appropriate promoter and polyA
signal for in vitro transcription. Purify the
mRNAs using RNeasy Mini Elute Cleanup Kit.
Run on an electrophoresis gel to check the size
and integrity of the mRNAs, and calculate the
concentration with a spectrophotometer. All
materials should be RNase free and the procedure
performed cautiously to avoid RNA degradation.
The samples can be aliquoted at a concentration
of 50 ng/μl, stored at -80°C, and thawed for use
when the embryos are ready. Only 1 process of
freezing/thawing is recommended.
IV. Microinjection of embryos with TALEN-coding
mRNAs.
7) Preparation of micromanipulation pipettes [28].
TIME: ~15-30 minutes.Figure
pipette
microma. Holding pipette (Figure 4A). Pull out the
borosilicate glass capillaries on the flame of an
alcohol lamp, then break at the tip leaving an
outside diameter of ~120-180 μm. Blunt the
broken end until the inner diameter is reduced
to ~20-30 μm. Bend the pipette close to the4 Photographs of holding and injection pipettes, microforge, pipett
. C. Microforge. D. Pipette puller. E. Micromanipulator. The holding and
anipulator.blunt end (about 300 μm back) at 30 degrees
with a microforge (Figure 4C).
b. Injection pipette (Figure 4B). Pull out the
borosilicate glass using a pipette puller
(Figure 4D) and the following parameters:
pressure 200, heat 505, pull 95, velocity 70,
and time-delay 80. Bend the pipette close to
the tip (about 400 μm back) at 30 degrees with
a microforge. The injection pipette should be
prepared on the same day or the day before
embryo injection, but not beforehand because
of tendency to become obstructed.
8) Preparation of rabbit embryos. TIME: ~6 days.
a. Inject at least 2 donor female rabbits
intramuscularly with 100 IU of pregnant
mare’s serum gonadotropin. Mate them after
72-120 hours, and then inject 100 IU of hCG
intravenously. Simultaneously, inject additional
female rabbits (we routinely prepare 2-3
additional ones for each pair of TALENs) with
100 IU of hCG. These extra rabbits will be
used as surrogate mothers (see step 11 below).
b. Prepare a 35 mm tissue culture dish
containing multiple droplets of embryo culture
medium, and a 4-well plate with each well
containing 500 μl of embryo culture medium.e puller and micromanipulator. A. Holding pipette. B. Injection
injection pipettes can be observed on both sides of the
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a 5% CO2 incubator at 38.5°C (body
temperature in rabbits) to balance for at least
3 hours before use.
c. Sacrifice the donor rabbits 18-20 hours after
hCG injection. Flush the fertilized oocytes
from the oviducts with pre-warmed (at 38.5°C)
embryo manipulation medium. Pick
pronuclear-stage embryos and wash them for 3
times in the droplets of embryo culture
medium prepared beforehand (see step 8b
above). Transfer the washed embryos to the
4-well plate containing embryo culture
medium (see step 8b above) and then put it
back to the incubator before use.
9) Micromanipulator set-up. TIME: ~10 minutes.
a. Mix (at 1:1 ratio) the paired TALEN-coding
mRNA solutions (each at a concentration of
50 ng/μl). Load the mixed mRNA solution into
the open end of the injection pipette with a
microloader. Attach the injection pipette to
one of the holders of the micromanipulator
(Figure 4E).
b. Attach the holding pipette to the other holder
of the micromanipulator (Figure 4E).
c. Prepare several droplets of pre-warmed
embryo manipulation medium in a 60 mm
tissue culture dish and cover them with
mineral oil (Figure 4E). Adjust the holding and
injection pipettes to the center of a droplet
(Figure 4E). Gently break the tip of the
injection pipette by hitting the holding pipette
(Additional file 1).
10) Embryo microinjection. TIME: ~10 minutes.
a. Take the 4-well plate containing embryos in
embryo culture medium (see step 8c above).
Put 30-40 pronuclear-stage embryos into a
single manipulation droplet in the 60 mm dish
(see step 9c above).
b. Adjust the holding and injection pipettes to
pick and inject the embryos individually with
5-10 pl of the TALEN-coding mRNA
solution. It is important to adjust the flow
rate of the mRNA solution beforehand by
injecting first into the perivitelline space (the
space between the zona pellucida and the cell
membrane) of one embryo; then inject
sequentially into the cytoplasm of each
embryo. The latter should produce slight
swelling (Additional file 2).
c. Wash the injected embryos 3 times in the
droplets of embryo culture medium prepared
beforehand (see step 8b above) and transfer to
the 4-well plate with embryo culture medium(see step 8b above). Place the 4-well plate back
in the incubator.
d. Half of the injected embryos will be lysed and
employed for confirming that the selected
TALENs cut the target sequence in vivo (see
step 5 above). These embryos need to be
maintained in the same 4-well plate with
embryo culture medium (see step 10b above)
in the incubator until they reach the blastocyst
stage (normally 4-5 days). The other half will
be transferred into the foster mother after
letting them recover for 2-3 hours in the same
4-well plate with embryo culture medium
inside the incubator. We perform both
procedures (in vivo testing of TALEN cutting
efficiency and transfer to foster mother)
simultaneously in our laboratories, but if the
methodology has just been set up then it may
be advisable to optimize (e.g., modifying the
mRNA concentration) the cutting efficiency
first.V. Embryo transfer to foster mother.
11) Transfer 8-14 good quality (as observed under the
microscope) embryos through the infundibulum
of the oviduct of each surrogate mother. TIME:
2-4 hours.
12) Detect pregnancy (by palpation) around 15 days
after embryo transfer. The rabbits will be born
by spontaneous delivery at around day 30 of
pregnancy.
VI. Knockout detection of newborn rabbits. TIME:
5-7 days.
13) Extract genomic DNA of newborn rabbits using
ear tissue and the appropriate lysis buffer.
Amplify the region of interest by PCR; a nested
PCR reaction can be employed if the desired
band is difficult to amplify. Use T-A cloning and
then sequencing to confirm the nature of the
mutation. Of note, if the TALENs acted during
or after the 2-cell stage the rabbits may be
chimeric, in which case the offspring will be
knockouts only if there is germline transmission.
VII. Off-target analysis. TIME: 1-2 weeks.
14) To determine the TALEN specificity, we use the
online e-PCR program (http://www.ncbi.nlm.nih.
gov/projects/e-pcr/) in NCBI. We routinely
choose potential off-target sites with no more
than 100 base pairs between the left and right
TALEN EBEs. In our previous study, we designed
primers for 2 and 6 potential off-target sites of
Rag1 and Rag2 TALENs, respectively. The
corresponding PCR products were sequenced
and compared with the original sequence, and
showed no evidence of off-target effects [22].
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The protocol described here allows the generation of
knockout rabbits using TALENs in ~6-8 weeks. This
methodology will expand the current uses of rabbits for
biomedical purposes, as they have significant advantages
compared with both rodents and larger animals including
pigs or cattle. Specifically, we anticipate a bright future for
immunodeficient rabbits in stem cell transplantation, and
as a preclinical model for gene therapy in humans. A
limitation of rabbits, and other non-rodent species as
well, is the lack of comprehensive materials for their
study (e.g., antibodies and gene expression arrays) [1]
and their incompletely sequenced and/or poorly annotated
genome. On the other hand, rabbits and other larger ani-
mals will likely be instrumental to develop new techniques
(e.g., surgical and imaging) and methodologies (e.g., proto-
cols for expanding/injecting cells or gene-therapy viral
vectors) similar to those that could be eventually required
in humans. For more complex genetic modifications (e.g.,
gene knock-in) than the 2 studies reported thus far using
ZFNs and TALENs [21,22], it is possible to simultaneously
inoculate rabbit fertilized eggs with designer nucleases and
donor plasmids/single-stranded oligonucleotides [29]. In
addition, there is a new type of genome editing platform
not yet reportedly tested in rabbits, the clustered regularly
interspaced short palindromic repeats (CRISPRs) and their
associated (Cas) proteins, which allows the simultaneous
modification of multiple genes [30]. CRISPRs/Cas are
based on an antiviral defense system in bacteria, and
their design/preparation is even simpler and less time
consuming than for TALENs. Moreover, it has being
reported that in at least some instances CRISPRs/Cas
can successfully target genes for which TALENs display
low cutting efficiency [31]. At this point, there is no
clear consensus regarding the risk of off-target effects
with each of the genome-editing platforms (ZFNs, TALENs
and CRISPRs/Cas). Nevertheless, these technologies are
evolving [32] and this issue will likely be significantly
minimized in the near future. Besides all these technical
considerations, it will be important to revise regulatory
and ethical issues, as research worldwide on these
modified mid-size and large animal models should be
compliant with the highest standards of animal care and
husbandry.Additional files
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